156 related articles for article (PubMed ID: 9116581)
1. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B.
Raddatz R; Lanier SM
Neurochem Int; 1997 Jan; 30(1):109-17. PubMed ID: 9116581
[TBL] [Abstract][Full Text] [Related]
2. Imidazoline/guanidinium binding domains on monoamine oxidases. Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B.
Raddatz R; Parini A; Lanier SM
J Biol Chem; 1995 Nov; 270(46):27961-8. PubMed ID: 7499273
[TBL] [Abstract][Full Text] [Related]
3. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.
Lanier B; Raddatz R; Bakthavachalam V; Coupry I; Neumeyer JL; Lanier SM
Mol Pharmacol; 1995 Oct; 48(4):703-10. PubMed ID: 7476897
[TBL] [Abstract][Full Text] [Related]
4. Visualization of multiple imidazoline/guanidinium-receptive sites.
Lanier SM; Ivkovic B; Singh I; Neumeyer JL; Bakthavachalam V
J Biol Chem; 1993 Jul; 268(21):16047-51. PubMed ID: 8340426
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of monoamine oxidase A and B activities by imidazol(ine)/guanidine drugs, nature of the interaction and distinction from I2-imidazoline receptors in rat liver.
Ozaita A; Olmos G; Boronat MA; Lizcano JM; Unzeta M; García-Sevilla JA
Br J Pharmacol; 1997 Jul; 121(5):901-12. PubMed ID: 9222546
[TBL] [Abstract][Full Text] [Related]
6. Relationship between I2 imidazoline binding sites and monoamine oxidase B in liver.
Remaury A; Ordener C; Shih J; Parini A
Ann N Y Acad Sci; 1999 Jun; 881():32-4. PubMed ID: 10415894
[TBL] [Abstract][Full Text] [Related]
7. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
Alemany R; Olmos G; García-Sevilla JA
Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):39-47. PubMed ID: 9228188
[TBL] [Abstract][Full Text] [Related]
8. Imidazoline binding domains on MAO-B. Localization and accessibility.
Raddatz R; Savic SL; Lanier SM
Ann N Y Acad Sci; 1999 Jun; 881():26-31. PubMed ID: 10415893
[TBL] [Abstract][Full Text] [Related]
9. Use of high affinity, radioiodinated probes for identification of imidazoline/guanidinium receptive sites.
Lanier SM; Lanier B; Bakthavachalam V; McGrath CR; Neumeyer JL
Ann N Y Acad Sci; 1995 Jul; 763():106-11. PubMed ID: 7677319
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the pharmacological and molecular heterogeneity of I(2)-imidazoline-binding proteins using monoamine oxidase-deficient mouse models.
Remaury A; Raddatz R; Ordener C; Savic S; Shih JC; Chen K; Seif I; De Maeyer E; Lanier SM; Parini A
Mol Pharmacol; 2000 Nov; 58(5):1085-90. PubMed ID: 11040057
[TBL] [Abstract][Full Text] [Related]
11. Localization of the imidazoline binding domain on monoamine oxidase B.
Raddatz R; Parini A; Lanier SM
Mol Pharmacol; 1997 Oct; 52(4):549-53. PubMed ID: 9380016
[TBL] [Abstract][Full Text] [Related]
12. Predominant expression of monoamine oxidase B isoform in rabbit renal proximal tubule: regulation by I2 imidazoline ligands in intact cells.
Gargalidis-Moudanos C; Remaury A; Pizzinat N; Parini A
Mol Pharmacol; 1997 Apr; 51(4):637-43. PubMed ID: 9106629
[TBL] [Abstract][Full Text] [Related]
13. [3H]Rilmenidine-labelled imidazoline-receptor binding sites co-localize with [3H]2-(benzofuranyl)-2-imidazoline-labelled imidazoline-receptor binding sites and monoamine oxidase-B in rabbit, but not rat, kidney.
King PR; Suzuki S; Hosseini AR; Iakovidis D; Nero TL; Jackman GP; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):118-28. PubMed ID: 9851560
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
[TBL] [Abstract][Full Text] [Related]
15. Pharmacology and subcellular distribution of [3H]rilmenidine binding sites in rat brain.
Hosseini AR; Jackman GP; King PR; Louis WJ; Gundlach AL
J Auton Nerv Syst; 1998 Oct; 72(2-3):129-36. PubMed ID: 9851561
[TBL] [Abstract][Full Text] [Related]
16. Modulation of MAO activity by imidazoline and guanidine derivatives.
Raasch W; Muhle H; Dominiak P
Ann N Y Acad Sci; 1999 Jun; 881():313-31. PubMed ID: 10415932
[TBL] [Abstract][Full Text] [Related]
17. Imidazoline-binding domains on monoamine oxidase B and subpopulations of enzyme.
Raddatz R; Savic SL; Bakthavachalam V; Lesnick J; Jasper JR; McGrath CR; Parini A; Lanier SM
J Pharmacol Exp Ther; 2000 Mar; 292(3):1135-45. PubMed ID: 10688633
[TBL] [Abstract][Full Text] [Related]
18. On the formation and nature of the imidazoline I2 binding site on human monoamine oxidase-B.
McDonald GR; Olivieri A; Ramsay RR; Holt A
Pharmacol Res; 2010 Dec; 62(6):475-88. PubMed ID: 20832472
[TBL] [Abstract][Full Text] [Related]
19. Development of a high-affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): intratissue distribution of IGRS in liver, forebrain, and kidney.
Ivkovic B; Bakthavachalam V; Zhang W; Parini A; Diz D; Bosch S; Neumeyer JL; Lanier SM
Mol Pharmacol; 1994 Jul; 46(1):15-23. PubMed ID: 8058049
[TBL] [Abstract][Full Text] [Related]
20. Characterization of mitochondrial imidazoline-guanidinium receptive sites (IGRS) in liver.
Tesson F; Prip-Buus C; Lemoine A; Pégorier JP; Parini A
Am J Hypertens; 1992 Apr; 5(4 Pt 2):80S-82S. PubMed ID: 1317714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
